V.ShilovE
In this 52-week trial of 1,698 people with type 2 diabetes whose blood sugar wasn't adequately controlled on Metformin, orforglipron outperformed oral semaglutide on every primary and secondary endpoint, including A1C reduction and weight loss, with improvements visible as early as four weeks
A doctor reviews your medical history, current health and treatment goals, and screens for the cautions above, and only then decides whether a medicine is appropriate and at what dose
The data supports this
They have to abide by FDA regulations, and they have to require a valid medical prescription from a medical doctor
Li G-Z, Liang H-F, Liao B, Zhang L, Ni Y-A, Zhou H-H, et al